martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Crude Oil Catapults After Iran Adopts Hardline Stance Despite U.S. Peace Efforts

View original at nasdaq.com
Crude Oil Catapults After Iran Adopts Hardline Stance Despite U.S. Peace Efforts (RTTNews) - Crude oil has skyrocketed on Friday as output-and-supply disruption risks dimmed the expectations of a resumption of export flows through U.S…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Oil shortage concerns that hit Asia could spread to Europe

    60% confidence
  • Iran had agreed to allow 10 oil tankers to pass through the strait to show seriousness about entering negotiations

    60% confidence
  • IRGC has full control over Strait of Hormuz and any ship attempting to pass will be met with harsh response

    60% confidence
  • Israeli strikes hit the heart of Tehran

    60% confidence
  • There are strong signs indicating Iran wants to negotiate

    60% confidence
  • Despite negativity from media, talks between U.S. and Iran are going very well

    60% confidence
  • Vessels connected to U.S. or Israel will be completely prohibited from transiting Strait of Hormuz

    60% confidence
  • Experts concerned about sharp jump in oil prices in near-term as situation appears far from de-escalation

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Crude Oil Catapults After Iran Adopts Hardline Stance Despite U.S. Peace Efforts — Source | Via News | es.VIA.NEWS